![]() Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | ![]() enVVeno Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). | ![]() QGel QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics. | ||
Founding Date | Founding Date 2009 | Founding Date 1987 | Founding Date 2010 | Founding Date 2009 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Cambridge, GB HQ | Locations Irvine, US HQ | Locations Oslo, NO HQ | Locations Lausanne, CH HQ |
Employees | Employees 407% decrease | Employees 1525% increase | Employees 442% decrease | Employees 147% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 100m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 4m (almost 6 years ago) | Latest funding round $ 12m (over 9 years ago) |
Total funding raised | Total funding raised $ 220.4m | Total funding raised N/A | Total funding raised $ 29m | Total funding raised $ 12m |

Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
View company
Oncoinvent AS is a privately held Norwegian company established in 2010.
View company
QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics.
View company